MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

01-06-2011, 09:31 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22. More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 07:26 AM.

free webpage hit counter